J. Graff, A. Mcnulty, K. Hanna, B. Konicek, R. Lynch et al., The Protein Kinase C??-Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts, Cancer Research, vol.65, issue.16, pp.7462-7471, 2005.
DOI : 10.1158/0008-5472.CAN-05-0071

B. Glimelius, M. Lahn, S. Gawande, A. Cleverly, C. Darstein et al., A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer, Annals of Oncology, vol.21, issue.5, pp.1020-1026, 2010.
DOI : 10.1093/annonc/mdp521

M. Robertson, B. Kahl, J. Vose, S. De-vos, M. Laughlin et al., Phase II Study of Enzastaurin, a Protein Kinase C Beta Inhibitor, in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Journal of Clinical Oncology, vol.25, issue.13, pp.1741-1747, 2007.
DOI : 10.1200/JCO.2006.09.3146

A. Ting, R. Schoon, R. Abraham, and P. Leibson, Interaction between protein kinase Cdependent and G protein-dependent pathways in the regulation of natural killer cell granule exocytosis, J Biol Chem, vol.267, pp.23957-62, 1992.

J. Bonnema, L. Karnitz, R. Schoon, R. Abraham, and P. Leibson, Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity, Journal of Experimental Medicine, vol.180, issue.4, pp.1427-1462, 1994.
DOI : 10.1084/jem.180.4.1427

A. Kvanta, C. Nordstedt, B. Fredholm, M. Gullberg, and M. Jondal, Evidence that Protein Kinase C Activation is Essential for Killing by IL-2-Activated Lymphocytes, Scandinavian Journal of Immunology, vol.244, issue.1
DOI : 10.1016/0167-5699(88)91201-7

A. Balendran, G. Hare, A. Kieloch, M. Williams, and D. Alessi, Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms, FEBS Letters, vol.272, issue.3, pp.217-240, 2000.
DOI : 10.1016/S0014-5793(00)02162-1

E. Beurel and R. Jope, Glycogen synthase kinase-3 promotes the synergistic action of interferon-?? on lipopolysaccharide-induced IL-6 production in RAW264.7 cells, Cellular Signalling, vol.21, issue.6, pp.978-85, 2009.
DOI : 10.1016/j.cellsig.2009.02.019

A. Aoukaty and R. Tan, Role for Glycogen Synthase Kinase-3 in NK Cell Cytotoxicity and X-Linked Lymphoproliferative Disease, The Journal of Immunology, vol.174, issue.8, pp.4551-4559, 2005.
DOI : 10.4049/jimmunol.174.8.4551

B. Perussia, Fc Receptors on Natural Killer Cells, Curr Top Microbiol Immunol, vol.230, pp.63-88, 1998.
DOI : 10.1007/978-3-642-46859-9_6

Y. Bryceson, M. March, H. Ljunggren, and E. Long, Activation, coactivation, and costimulation of resting human natural killer cells, Immunological Reviews, vol.137, issue.1, pp.73-91, 2006.
DOI : 10.1158/0008-5472.CAN-05-4603

A. Moretta, E. Marcenaro, S. Parolini, G. Ferlazzo, and L. Moretta, NK cells at the interface between innate and adaptive immunity, Cell Death and Differentiation, vol.178, issue.2, pp.226-259, 2008.
DOI : 10.1182/blood-2004-10-4035

E. Vivier, J. Nunès, and F. Vély, Natural Killer Cell Signaling Pathways, Science, vol.306, issue.5701, pp.1517-1526, 2004.
DOI : 10.1126/science.1103478

URL : https://hal.archives-ouvertes.fr/hal-00080580

L. Lanier, Natural killer cell receptor signaling, Current Opinion in Immunology, vol.15, issue.3, pp.308-322, 2003.
DOI : 10.1016/S0952-7915(03)00039-6

J. Upshaw, L. Arneson, R. Schoon, C. Dick, D. Billadeau et al., NKG2D- mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and

D. Billadeau, J. Upshaw, R. Schoon, C. Dick, and P. Leibson, NKG2D-DAP10 triggers human NK cell???mediated killing via a Syk-independent regulatory pathway, Nature Immunology, vol.4, issue.6, pp.557-64, 2003.
DOI : 10.1038/ni929

D. Graham, M. Cella, E. Giurisato, K. Fujikawa, A. Miletic et al., Vav1 Controls DAP10-Mediated Natural Cytotoxicity by Regulating Actin and Microtubule Dynamics, The Journal of Immunology, vol.177, issue.4, pp.2349-55, 2006.
DOI : 10.4049/jimmunol.177.4.2349

I. Tassi, M. Cella, R. Presti, A. Colucci, S. Gilfillan et al., NK cell-activating receptors require PKC-?? for sustained signaling, transcriptional activation, and IFN-?? secretion, Blood, vol.112, issue.10, pp.4109-4125, 2008.
DOI : 10.1182/blood-2008-02-139527

S. Chiesa, M. Mingueneau, N. Fuseri, B. Malissen, D. Raulet et al., Multiplicity and plasticity of natural killer cell signaling pathways, Blood, vol.107, issue.6, pp.2364-72, 2006.
DOI : 10.1182/blood-2005-08-3504

URL : https://hal.archives-ouvertes.fr/hal-00080580

K. Jiang, B. Zhong, D. Gilvary, B. Corliss, E. Hong-geller et al., Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells, Nature Immunology, vol.1, issue.5, pp.419-444, 2000.
DOI : 10.1038/80859

K. Jiang, B. Zhong, D. Gilvary, B. Corliss, E. Vivier et al., Syk Regulation of Phosphoinositide 3-Kinase-Dependent NK Cell Function, The Journal of Immunology, vol.168, issue.7, pp.3155-64, 2002.
DOI : 10.4049/jimmunol.168.7.3155

I. Tassi, R. Presti, S. Kim, W. Yokoyama, S. Gilfillan et al., Phospholipase C-??2 Is a Critical Signaling Mediator for Murine NK Cell Activating Receptors, The Journal of Immunology, vol.175, issue.2, pp.749-54, 2005.
DOI : 10.4049/jimmunol.175.2.749

A. Caraux, N. Kim, S. Bell, S. Zompi, T. Ranson et al., Phospholipase C-??2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells, Blood, vol.107, issue.3, pp.994-1002, 2006.
DOI : 10.1182/blood-2005-06-2428

J. Regunathan, Y. Chen, S. Kutlesa, X. Dai, L. Bai et al., Differential and Nonredundant Roles of Phospholipase C??2 and Phospholipase C??1 in the Terminal Maturation of NK Cells, The Journal of Immunology, vol.177, issue.8, pp.5365-76, 2006.
DOI : 10.4049/jimmunol.177.8.5365

J. Upshaw, R. Schoon, C. Dick, D. Billadeau, and P. Leibson, The Isoforms of Phospholipase C-?? Are Differentially Used by Distinct Human NK Activating Receptors, The Journal of Immunology, vol.175, issue.1, pp.213-221, 2005.
DOI : 10.4049/jimmunol.175.1.213

M. Cella, K. Fujikawa, I. Tassi, S. Kim, K. Latinis et al., Differential Requirements for Vav Proteins in DAP10- and ITAM-mediated NK Cell Cytotoxicity, The Journal of Experimental Medicine, vol.162, issue.6, pp.817-840, 2004.
DOI : 10.1038/ni930

R. Trotta, K. Puorro, M. Paroli, L. Azzoni, B. Abebe et al., Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases, J Immunol, vol.161, pp.6648-56, 1998.

L. Lanier, Up on the tightrope: natural killer cell activation and inhibition, Nature Immunology, vol.179, issue.5, pp.495-502, 2008.
DOI : 10.1371/journal.pone.0000326

J. Aguiló, J. Garaude, J. Pardo, M. Villalba, and A. Anel, Protein Kinase C-?? Is Required for NK Cell Activation and In Vivo Control of Tumor Progression, The Journal of Immunology, vol.182, issue.4, pp.1972-81, 2009.
DOI : 10.4049/jimmunol.0801820

T. Steele and Z. Brahmi, Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event, J Immunol, vol.141, pp.3164-3173, 1988.

K. Page, D. Chaudhary, S. Goldman, and M. Kasaian, Natural killer cells from protein kinase C ??-/- mice stimulated with interleukin-12 are deficient in production of interferon-??, Journal of Leukocyte Biology, vol.83, issue.5, pp.1267-76, 2008.
DOI : 10.1189/jlb.1107745

J. Zhang, P. Anastasiadis, Y. Liu, E. Thompson, and A. Fields, Protein Kinase C (PKC) ??II Induces Cell Invasion through a Ras/Mek-, PKC??/Rac 1-dependent Signaling Pathway, Journal of Biological Chemistry, vol.279, issue.21, pp.22118-22141, 2004.
DOI : 10.1074/jbc.M400774200

C. Partovian and M. Simons, Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase C?? in endothelial cells, Cellular Signalling, vol.16, issue.8, pp.951-958, 2004.
DOI : 10.1016/j.cellsig.2004.01.008

S. Aeder, P. Martin, J. Soh, and I. Hussaini, PKC-?? mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways, Oncogene, vol.23, issue.56, pp.9062-9071, 2004.
DOI : 10.1038/sj.onc.1208093

X. Fang, S. Yu, J. Tanyi, Y. Lu, J. Woodgett et al., Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation

N. Goode, K. Hughes, J. Woodgett, and P. Parker, Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes, J Biol Chem, vol.267, pp.16878-82, 1992.

D. Cross, D. Alessi, P. Cohen, M. Andjelkovich, and B. Hemmings, Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B, Nature, vol.270, issue.6559, pp.785-794, 1995.
DOI : 10.1038/378785a0

X. Fang, S. Yu, J. Tanyi, Y. Lu, J. Woodgett et al., Convergence of Multiple Signaling Cascades at Glycogen Synthase Kinase 3: Edg Receptor-Mediated Phosphorylation and Inactivation by Lysophosphatidic Acid through a Protein Kinase C-Dependent Intracellular Pathway, Molecular and Cellular Biology, vol.22, issue.7, pp.2099-110, 2002.
DOI : 10.1128/MCB.22.7.2099-2110.2002

R. Herbst, Y. Oh, A. Wagle, and M. Lahn, Enzastaurin, a Protein Kinase C?? Selective Inhibitor, and Its Potential Application as an Anticancer Agent in Lung Cancer, Clinical Cancer Research, vol.13, issue.15, pp.4641-4647, 2007.
DOI : 10.1158/1078-0432.CCR-07-0538

K. Podar, M. Raab, J. Zhang, D. Mcmillin, I. Breitkreutz et al., Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl), Blood, vol.109, issue.4, pp.1669-77, 2007.
DOI : 10.1182/blood-2006-08-042747

C. Holler, J. Piñón, U. Denk, C. Heyder, S. Hofbauer et al., PKC?? is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKC?? as a therapeutic target in chronic lymphocytic leukemia, Blood, vol.113, issue.12, pp.2791-2795, 2009.
DOI : 10.1182/blood-2008-06-160713

R. Jope and G. Johnson, The glamour and gloom of glycogen synthase kinase-3, Trends in Biochemical Sciences, vol.29, issue.2, pp.95-102, 2004.
DOI : 10.1016/j.tibs.2003.12.004

D. Servi, B. Heramni, A. Medunjanin, S. Mayer, and D. , Impact of PKC?? on estrogen receptor localization and activity in breast cancer cells, Oncogene, vol.47, issue.31, pp.4946-55, 2005.
DOI : 10.1016/S0014-5793(00)01234-5

M. Szamel, U. Ebel, P. Uciechowski, V. Kaever, and K. Resch, T cell antigen receptor dependent signalling in human lymphocytes: cholera toxin inhibits interleukin-2 receptor expression but not interleukin-2 synthesis by preventing activation of a protein kinase C isotype, PKC-??, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1356, issue.2
DOI : 10.1016/S0167-4889(96)00174-7

J. Gómez, C. Pitton, A. García, A. Martinez-de-aragón, A. Silva et al., The ?? Isoform of Protein Kinase C Controls Interleukin-2-Mediated Proliferation in a Murine T Cell Line: Evidence for an Additional Role of Protein Kinase C ?? and ??, Experimental Cell Research, vol.218, issue.1, pp.105-118, 1995.
DOI : 10.1006/excr.1995.1136

M. Szamel, A. Appel, R. Schwinzer, and K. Resch, Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR, J Immunol, vol.160, pp.2207-2221, 1998.

A. Shenoy and Z. Brahmi, Inhibition of the calpain-mediated proteolysis of protein kinase C enhances lytic activity in human NK cells, Cellular Immunology, vol.138, issue.1, pp.24-34, 1991.
DOI : 10.1016/0008-8749(91)90129-Y

A. Shenoy, R. Sidner, and Z. Brahmi, Signal Transduction in Cytotoxic Lymphocytes: Decreased Calcium influx in NK Cell inactivated with Sensitive Target Cells, Cellular Immunology, vol.147, issue.2, pp.294-301, 1993.
DOI : 10.1006/cimm.1993.1070

C. Zorn, S. Keck, R. Hendriks, M. Leitges, M. Freudenberg et al., Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells, Cellular Signalling, vol.21, issue.1, pp.79-86, 2009.
DOI : 10.1016/j.cellsig.2008.09.010

H. Kim, K. Lee, S. Park, S. Kim, Y. Yang et al., Anti-cancer activity and mechanistic features of a NK cell activating molecule, Cancer Immunology, Immunotherapy, vol.105, issue.Pt 2, pp.1691-1700, 2009.
DOI : 10.1007/s00262-009-0680-0